Adma Biologics (ADMA) EBT (2011 - 2025)
Adma Biologics (ADMA) posted EBT of -$121.1 million for Q4 2025, down 354.78% on a QoQ basis from $47.5 million in Q3 2025, and down 448.75% year-over-year from $34.7 million in Q4 2024.
Adma Biologics (ADMA) EBT (2011 - 2025) Analysis & Trends
Adma Biologics' EBT history runs 13 years deep, the most recent figure standing at -$121.1 million for Q4 2025.
- Quarterly EBT fell 448.75% year-over-year to -$121.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 100.0% YoY) and the FY2024 annual result came in at $125.7 million, changed N/A from the prior year.
- EBT was -$121.1 million for Q4 2025 at Adma Biologics, down from $47.5 million in the prior quarter.
- Across five years, EBT topped out at $47.5 million in Q3 2025 and bottomed at -$121.1 million in Q4 2025.
- A 5-year average of -$988276.4 and a median of -$6.6 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT soared 1332.71% — and 2025, when it sank 448.75%.
- Adma Biologics' EBT stood at -$25.1 million in 2021, then rose by 25.89% to -$18.6 million in 2022, then surged by 156.85% to $10.6 million in 2023, then soared by 227.67% to $34.7 million in 2024, then sank by 448.75% to -$121.1 million in 2025.
- Business Quant data shows ADMA's EBT at -$121.1 million in Q4 2025, $47.5 million in Q3 2025, and $40.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | -121.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -121.06 Mn |
| Sep 30, 2025 | 47.52 Mn |
| Jun 30, 2025 | 40.10 Mn |
| Mar 31, 2025 | 33.45 Mn |
| Dec 31, 2024 | 34.71 Mn |
| Sep 30, 2024 | 36.75 Mn |
| Jun 30, 2024 | 35.85 Mn |
| Mar 31, 2024 | 18.40 Mn |
| Dec 31, 2023 | 10.59 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | -6.37 Mn |
| Mar 31, 2023 | -6.79 Mn |
| Dec 31, 2022 | -18.64 Mn |
| Sep 30, 2022 | -14.89 Mn |
| Jun 30, 2022 | -13.75 Mn |
| Mar 31, 2022 | -18.17 Mn |
| Dec 31, 2021 | -25.15 Mn |
| Sep 30, 2021 | -17.73 Mn |
| Jun 30, 2021 | -18.82 Mn |
| Mar 31, 2021 | -18.34 Mn |